The present study was conducted over the period from April 2021 to May 2022 in the Microbiology Laboratory at at the High Institute of Public Health (HIPH) and the Clinical Pathology Laboratory at ...
To explore the use of autologous platelet-rich plasma (PRP) as a potential therapeutic adjuvant strategy for treating degenerative lamellar macular holes (LMHs). Seven consecutive patients (8 eyes) ...
Platelet-rich plasma (PRP) is a fraction of blood plasma; its concentration of platelets is of great value in regenerative medicine as they are essential in accelerating healing and repairing tissue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results